2021
25843 Tapinarof cream 1% once daily for plaque psoriasis: Patient-reported outcomes from two pivotal phase 3 trials
Bissonnette R, Strober B, Lebwohl M, Bagel J, Del Rosso J, Merola J, Bhatia N, Yamauchi P, Brown P, Rubenstein D, Tallman A. 25843 Tapinarof cream 1% once daily for plaque psoriasis: Patient-reported outcomes from two pivotal phase 3 trials. Journal Of The American Academy Of Dermatology 2021, 85: ab71. DOI: 10.1016/j.jaad.2021.06.310.Peer-Reviewed Original Research
2020
Tapinarof Cream 1% QD for the Treatment of Plaque Psoriasis: Efficacy and Safety in Two Pivotal Phase 3 Trials
Lebwohl M, Stein Gold L, Strober B, Armstrong A, Hong H, Kircik L, Soung J, Fromowitz J, Guenthner S, Piscitelli S, Rubenstein D, Brown P, Tallman A, Bissonnette R. Tapinarof Cream 1% QD for the Treatment of Plaque Psoriasis: Efficacy and Safety in Two Pivotal Phase 3 Trials. SKIN The Journal Of Cutaneous Medicine 2020, 4: s75. DOI: 10.25251/skin.4.supp.75.Peer-Reviewed Original Research